Home » Uncategorized

Is Gilead (GILD) Stock a Good Buy?

Gilead, a biotech company that treats serious viruses like HIV, reported that they are curing Coronavirus patients with a drug called Remdesivir. The company has cured over 100+ patients who tested as positive for COVID-19.

GILD stock is up big and the stock has been going up ever since the Coronavirus caused a global pandemic crisis. Biotech stocks are an interesting sector because they would profit handsomely if the drug proved effective.

Drugs are better than vaccines so let's hope Gilead comes to treat patients and come up with an effective cure. Along with its robust profits and strong dividend, GILD stock looks like a strong buy for biotech investors.

Leave a Comment